جست‌وجوی استاد و پژوهشگر

Fran Aweekaمشاهده پروفایل

استاد

• HIV Pharmacology
• Malaria Pharmacology
• Tuberculosis Pharmacology
• +۶ مورد دیگر

Fran Aweeka is a Professor and Vice Chair of Research at the Department of Clinical Pharmacy, University of California San Francisco (UCSF) School of Pharmacy . She directs the Drug Research Unit (DRU) and serves as the Pharmacology Core Lead for the UCSF Center for AIDS Research . Her research focuses on pharmacokinetic and pharmacodynamic studies of HIV, malaria, and tuberculosis drugs, particularly in vulnerable populations in Africa and the U.S. She actively contributes to the PharmD degree program as a co-director of the Inquiry component and mentors students in pharmacology and international research. As a clinical pharmacologist with over 25 years of experience, Dr. Aweeka investigates drug interactions in co-infected patients, pharmacokinetics in pregnancy and pediatric populations, and mechanisms of HIV-associated inflammation. Her work includes PI roles on NIH R01 grants and leadership in global health initiatives like seasonal malaria chemoprevention studies in Uganda. The DRU under her direction provides advanced analytical techniques for drug quantification in plasma and target tissues, supporting over 30 NIH studies. Her recent research trends include pharmacokinetic-pharmacodynamic modeling of antimalarial and antiretroviral combinations, microvolume plasma assays , and drug exposure-response relationships in resource-limited settings. Publications from 2021–2025 reflect these areas, with emphasis on pregnancy pharmacokinetics , pediatric dosing , and global health pharmacology . Dr. Aweeka holds a PharmD from UCSF (1985) and a BS in Biological Sciences from USC (1981). She is a licensed pharmacist in California and has completed leadership programs like the Mentor Development Program . Her lab supports collaborative projects across national and international institutions, focusing on drug quantification in plasma, dried blood spots, and target cells.

Ingmar Glaucheمشاهده پروفایل

استاد

• Hematopoietic Stem Cell Biology
• Clonal Competition Dynamics
• Stem Cell Aging
• +۵ مورد دیگر

Prof. Dr. Ingmar Glauche serves as Deputy Institute Director at the Institute for Medical Informatics and Biometrics within TU Dresden's Medical Faculty . He leads the Theoretical Stem Cell Biology research group and coordinates the institute's teaching activities. As an elected member of TU Dresden's extended senate, he contributes to institutional governance. Academic focus on hematopoietic stem cell biology Expertise in computational modeling Key roles in leukemia research and stem cell transplantation Research interests span clonal competition , stem cell aging , and proliferation-differentiation control , with applications in chronic/acute myeloid leukemia and inherited bone marrow failure . His work combines differential equation models and agent-based simulations to study clonal dynamics , spatial organization , and feedback mechanisms in stem cell systems. Recent publications analyze clonal dominance mechanisms (2025), pediatric CML therapy monitoring (2023), and stem cell aging (2022). Collaborations include DFG , BMBF , and Wilhelm Sander-Stiftung projects like TKI-Stop and MinimaL . Current students include Andrea Gottschalk and Thomas Zerjatke , while former advisees include Christoph Baldow and Helene Hoffmann . 2025: Blood - Myeloid bias mechanisms 2024: BMC Medical Education - Competence analysis 2024: Leukemia - Clonal hematopoiesis 2023: PLOS Digital Health - Data integration 2022: Nature Communications - Clonal reconstruction

• Pediatrics
• Pediatric Gastroenterology
• Hepatology
• +۱۱ مورد دیگر

Catherine Larson-Nath is an Associate Professor in the Department of Pediatric Gastroenterology, Hepatology & Nutrition at the University of Minnesota Medical School. Her clinical and research work focuses on pediatric intestinal failure, Alagille syndrome, and related liver and nutritional disorders. Research Interests: Dr. Larson-Nath's expertise spans pediatric gastroenterology, hepatology, and clinical nutrition. Her research emphasizes the natural history of Alagille syndrome, intestinal failure management, catheter-related infections, body composition assessment, and nutritional interventions in children with complex liver and gastrointestinal diseases. She is particularly involved in rare disease research and international cohort studies. Recent Research Trends: Her most recent publications (2023–2025) focus on the long-term outcomes of maralixibat treatment in Alagille syndrome, catheter salvage in pediatric intestinal failure, and the impact of genetic and non-genetic factors on disease expression. These works reflect a strong commitment to improving clinical care through evidence-based, patient-centered research. Scientific Contributions: Principal Investigator (PI) of the Intestinal Failure Registry funded by The Transplantation Society. PI of The Global Alagille Alliance (GALA) Study, a major international research initiative. Co-Investigator on the NIH-funded SMART Bottle STTR Phase II project. Advising and Grants: Dr. Larson-Nath leads multiple funded research projects, including international collaborations and NIH-supported studies. She actively contributes to advancing clinical guidelines and has been cited in policy documents and clinical practice sources. While no formal advisees are listed, her leadership in multicenter studies indicates significant mentorship and team coordination. Labs and Teams: She is a key member of multidisciplinary teams focused on pediatric liver disease and intestinal rehabilitation, collaborating with surgeons, nutritionists, and geneticists. Her work with the GALA study group highlights her leadership in global rare disease research networks.

• Mechanobiology
• Computational Mechanics
• Soft Matter Physics
• +۷ مورد دیگر

Marino Arroyo is a Professor at the Universitat Politècnica de Catalunya (UPC), affiliated with the Research Center in Numerical Methods in Applied Science and Engineering (LaCàN). He is also associated with CIMNE and the Institute of Bioengineering of Catalunya (IBEC). His work focuses on computational and theoretical modeling of biological systems, particularly epithelial mechanics, active matter, and biomembranes. He holds the Icrea Academia Award, recognizing his contributions to mechanobiology and soft matter physics. Education: PhD in Mechanical Engineering, Northwestern University (2003) BS/MS in Civil Engineering, UPC Postdoc at Caltech with Michael Ortiz (2003-2004) Research Interests: Combines mathematical modeling, mechanics, and computations to study small-scale material behavior and biological systems. Current focus includes cell/tissue mechanobiology, active living materials, and bio-inspired materials. Key themes are nonlinear mechanics of 2D materials (graphene, biomembranes), continuum mechanics, and molecular-to-continuum modeling. Recent Article Trends: Focuses on multiscale epithelial mechanics, active gels, hydraulic fracture in biological systems, and mechanochemical feedback in cellular membranes. Recent work includes modeling curved epithelial shells, nematic patterns in cytoskeletal layers, and shape-programmable living surfaces. Scientific Awards: Icrea Academia Awardee Advising & Grants: Supervised over 20 PhD students, many of whom hold prestigious postdocs or academic positions. Collaborates with experimental groups (e.g., Xavier Trepat, Danijela Vignjevic). Current projects include NIH-funded studies on epithelial mechanics and ERC grants for computational modeling. Labs/Teams: Leads LaCàN's biomaterials group, integrating computational mechanics with experimental biology. Active in interdisciplinary collaborations across UPC, IBEC, and international institutions.

• Endocrinology
• Diabetes
• Incretin Biology
• +۴ مورد دیگر

Daniel J. Drucker is a University Professor of Medicine at the University of Toronto and Senior Investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health. His groundbreaking research focuses on glucagon-like peptides (GLP-1 and GLP-2), revolutionizing treatments for diabetes, obesity, and intestinal failure. He discovered GLP-1's roles in insulin secretion, cardioprotection, and inflammation reduction, and GLP-2's application in short bowel syndrome therapy. Education : MD, University of Toronto (1980) Internship at Johns Hopkins Hospital Residencies in Internal Medicine and Endocrinology at University of Toronto Research Interests : Drucker's work spans incretin biology, gut hormone therapeutics, metabolic regulation, and inflammation control. His discoveries enabled GLP-1 receptor agonists (e.g., exenatide) and DPP-4 inhibitors for diabetes, along with teduglutide for intestinal failure. Recent studies explore GLP-1's anti-inflammatory actions and cardiometabolic protection. Awards and Honors : Wolf Prize in Medicine (2023) Breakthrough Prize in Life Sciences (2025) Canada Gairdner International Award (2021) Fellow of the Royal Society (2015) Princess of Asturias Award (2024) Time100 Most Influential People (2024) Leadership : Holds the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology. His lab at Lunenfeld-Tanenbaum Research Institute drives innovation in peptide therapeutics.

Fiona Brittonمشاهده پروفایل

استاد

• Ion-channel physiology
• Cardiovascular electrophysiology
• Smooth-muscle excitability
• +۴ مورد دیگر

Fiona Britton is Chair and Professor of Biomedical Sciences in the School of Dental Medicine at the University of Nevada, Las Vegas (UNLV). Holding a B.Sc. and Ph.D. from Ulster University, Northern Ireland, she has built an internationally recognized research program focused on ion-channel physiology, smooth-muscle excitability, and cardiovascular regulation. Education Ph.D., Ulster University, Northern Ireland B.Sc., Ulster University, Northern Ireland Research Focus Professor Britton’s work centers on the molecular and functional characterisation of calcium-activated chloride channels (CaCCs), bestrophins, anoctamins/TMEM16, TRPV channels, and voltage-gated calcium channels. Using patch-clamp electrophysiology, molecular biology, and transgenic models, her group investigates how these channels control arterial tone, cardiac pacemaking, gastrointestinal motility, and uterine blood flow. A recurring theme is the integration of ion-channel activity with intracellular Ca²⁺ handling, offering insights into hypertension, heart failure, and pregnancy-related vascular adaptation. Across more than 40 peer-reviewed publications spanning 1997-2021, her studies trace an arc from cloning and expression of cardiac chloride channels (ClC-2, ClC-3, bestrophins) to demonstrating their physiological impact in smooth-muscle organs. Recent work has illuminated β-adrenoceptor subtype pharmacology in cremaster arterioles and TRPV3-mediated vasodilation in uterine vasculature, underscoring translational relevance to reproductive and cardiovascular medicine. Contact Email: fiona.britton@unlv.edu Phone: 702-774-8680 Mail Code: 7412, University of Nevada, Las Vegas

• Cancer Stem Cells
• Tumor Microenvironment
• Precision Medicine
• +۷ مورد دیگر

Giorgio Stassi serves as a Professor in the Department of Surgical and Oncological Disciplines at the School of Medicine and Surgery , University of Palermo . His research focuses on cancer stem cells (CSCs) across colorectal, breast, and thyroid malignancies, with emphasis on microenvironment interactions and therapy resistance mechanisms. Office hours are held weekly at the Laboratory of Cellular and Molecular Pathophysiology in Palermo. His research interests include: Precision Medicine applications in CSC-targeted therapies Immunological profiling of tumor microenvironments Epigenetic and metabolic drivers of chemoresistance Bioinformatic analysis of CSC phenotypes Drug repurposing for CSC eradication Recent publications demonstrate a clear trend toward computational oncology and immunomicroenvironment engineering , with notable work on tumor-on-chip systems, NGS-based prognostics, and macrophage-CSC crosstalk. Key journals include Magazine article and Review essay formats addressing clinical translation of laboratory findings. No scientific awards were documented in the provided materials. His supervisory activities include thesis guidance ("Tesi curate") and Erasmus program coordination, though specific students and projects aren't listed. Research is conducted primarily at the Laboratory of Cellular and Molecular Pathophysiology , with institutional support from the ATeN Center and ASCENT Advanced Studies Centre.

• Colorectal Surgery
• Surgical Outcomes Research
• Pelvic Exenteration
• +۵ مورد دیگر

Associate Professor Cherry Koh is a Colorectal Surgeon and academic at the University of Sydney's Central Clinical School. She specializes in minimally invasive colorectal surgery, pelvic exenteration, and surgical outcomes research. Her clinical and academic roles include surgical training, research supervision, and leadership in surgical education. Education and Training: Trained at St Vincent’s Hospital (Melbourne), The Alfred Hospital (Melbourne), Royal Prince Alfred Hospital (Sydney), and Oxford's John Radcliffe Hospital. Masters of Surgery in Colorectal Surgery from the University of Sydney. Research Interests: Pelvic exenteration surgery outcomes and decision-making. Impact of prehabilitation on surgical recovery. Patient-reported outcomes in colorectal cancer management. Advances in minimally invasive surgical techniques. Awards: Recipient of multiple national and international research fellowships (e.g., Royal Australasian College of Surgeons Foundation Fellowship). Awarded Best Teacher Award by Royal Prince Alfred Hospital. Teaching and Mentorship: Course Director for advanced pelvic anatomy workshops. Supervises Central Clinical School research students and SOuRCe-based MD programs. Labs/Teams: Active contributor to the Surgical Outcomes Research Centre (SOuRCe) at Royal Prince Alfred Hospital. Collaborates internationally on colorectal cancer and surgical outcomes research.

• Liver Transplantation
• Surgery
• Hepatobiliary Surgery
• +۳ مورد دیگر

Marieke de Boer is a researcher affiliated with the University of Groningen's Faculty of Medical Sciences and the Groningen Institute for Organ Transplantation (GIOT). Her work focuses on hepatobiliary surgery, liver transplantation, and surgical oncology, particularly in cholangiocarcinoma and post-transplant outcomes. She has contributed to 99 research outputs, including studies on resectability classifications, surgical outcomes, and molecular signatures in transplant recipients. She actively participates in international collaborations and has organized events such as the European-African Hepato-Pancreato-Biliary Association Congress and the Alpine Liver and Pancreatic Surgery Meeting. Her research addresses topics like failure-to-rescue rates in cholangiocarcinoma surgery, cellular mechanisms in intestinal grafts, and quality-of-life metrics in kidney transplant patients. She co-authored national consensus guidelines on resectability criteria for perihilar cholangiocarcinoma. Media highlights include pioneering liver transplantations for colorectal cancer patients with liver metastases and contributions to pandemic-related material aid for Suriname.

Jared P. Rutterمشاهده پروفایل

استاد

• Metabolism
• Metabolism Regulation
• Cell Signaling
• +۳ مورد دیگر

Jared P. Rutter, PhD, is a Professor in the Department of Biochemistry at the University of Utah and a member of the Nuclear Control of Cell Growth and Differentiation Program at Huntsman Cancer Institute. His research focuses on how cells sense and regulate energy needs for growth, with particular emphasis on metabolic pathways and their roles in cancer and metabolic diseases. Education: Bachelor's degree in Biochemistry from Brigham Young University PhD from the University of Texas Southwestern Medical Center, advised by Steven L. McKnight Postdoctoral Fellowship at the University of Texas Southwestern Medical Center Research Interests: Metabolism regulation, cell signaling, mitochondrial function, and the interplay between energy metabolism and cancer biology. His work explores how metabolic pathways are rewired in cancer cells and how these pathways can be targeted for therapy. Recent Research Trends: His articles emphasize mitochondrial metabolism, lactate utilization, and the role of pyruvate in cell growth and disease. Key themes include metabolic reprogramming in cancer, cardiac metabolism, and the development of novel therapeutic strategies. Labs/Teams: Leads the Rutter Lab, which integrates biochemical, genetic, and computational approaches to study metabolic control mechanisms. Grants and Collaborations: Active in collaborative projects on metabolic disease mechanisms and cancer metabolism, with funding from NIH and other agencies.

Kevin Dammanمشاهده پروفایل

استاد بالینی

• Heart Failure
• Cardiorenal Interaction
• Clinical Cardiology
• +۳ مورد دیگر

Dr. Kevin Damman is a Clinical Professor and Cardiologist at the University Medical Center Groningen (UMCG), affiliated with the Faculty of Medical Sciences at the University of Groningen. He leads the heart transplant and left ventricular assist device program, focusing on advanced heart failure and cardiorenal interactions. His research emphasizes improving acute heart failure treatments, including SGLT2 inhibitors and diuretic therapy optimization. He holds editorial roles at the European Journal of Heart Failure and chairs the MCS Working Group of the Netherlands Society of Cardiology. Dr. Damman is a co-investigator in pivotal studies like EMPA-RESPONSE-AHF and ADVOR, exploring novel therapies in heart failure. His research spans acute heart failure pathophysiology, cardiorenal syndrome, and translational medicine through initiatives like the TransplantLines biobank. He contributes to clinical guidelines on diuretic titration and natriuresis monitoring. Dr. Damman actively participates in international working groups (ESC HFA) and registries (EUROMACS), shaping global standards in heart failure care. His work bridges clinical practice and research, aiming to enhance patient outcomes through innovative therapies and precision medicine approaches. Grants and studies include leadership roles in the PUSH-AHF and ADVOR trials, investigating decongestive therapies and acetazolamide respectively. He collaborates with multidisciplinary teams across Europe, emphasizing the integration of renal function assessment into heart failure management strategies. Dr. Damman’s contributions extend to public engagement through expert commentary on high-profile transplant cases and emerging treatments in cardiovascular medicine.

Lydia Matesicمشاهده پروفایل

دانشیار

• Stem Cells & Developmental Biology
• Biology of Cellular Stress
• Molecular Biology
• +۳ مورد دیگر

Lydia Matesic is an Associate Professor in the Department of Biological Sciences at the University of South Carolina , affiliated with the McCausland College of Arts and Sciences. Her research focuses on the functional roles of ubiquitin ligases ITCH and WWP1 in maintaining cellular homeostasis under stress conditions, with implications in autoimmunity, inflammation, cancer, and cardiovascular biology. Expertise in Stem Cells & Developmental Biology Specialized in Biology of Cellular Stress and ubiquitin-mediated signaling Leadership as Director of the Cardiovascular Technology Program Her research explores how ITCH and WWP1 regulate protein turnover in immune cells and cardiac tissues, contributing to diseases like inflammatory bowel disease, cancer, and cardiac arrhythmias. Key findings include ITCH's role in inflammatory barrier maintenance and WWP1's involvement in age-associated cardiac dysfunction. Recent publications highlight investigations into: WWP1's role in myocardial aging and breast cancer therapy ITCH's regulation of hematopoietic stem cells and intestinal epithelial homeostasis Modulation of inflammatory signaling pathways via ubiquitin-editing enzymes Development of fetal lung organoid models for interstitial lung disease Lydia's work bridges molecular mechanisms with translational applications in chronic diseases, though no scientific awards or student advisement details are explicitly listed.

Philippe R. Bauerمشاهده پروفایل

پزشک-پژوهشگر

• Critical Care Medicine
• Pulmonary Diseases
• Immunocompromised Patients in ICU
• +۴ مورد دیگر

Philippe R. Bauer, M.D., Ph.D., is a prominent physician scientist at the Mayo Clinic specializing in Critical Care Medicine within the Department of Pulmonary and Critical Care Medicine. With a dual focus on clinical practice and research, he has led multinational studies on immunocompromised patient outcomes in ICUs and contributed to critical care guidelines for conditions like ARDS and sepsis.

Kai Erdmannمشاهده پروفایل

مدرس ارشد

• Molecular Cell Biology
• Mechanobiology
• Mechanotransduction
• +۶ مورد دیگر

Dr Kai Erdmann is a Senior Lecturer in Molecular Cell Biology at the School of Biosciences, The University of Sheffield, where he has been employed since 2012. His academic career includes leading his research group at Ruhr-University Bochum (2006-2012) and postdoctoral work at Yale University School of Medicine (2005-2006). He obtained his PhD at Ruhr-University Bochum (1993-1996) and was a Feodor Lynen Fellow (2003-2005). Dr Erdmann's research focuses on molecular and cellular mechanobiology , particularly how mechanical cues regulate mechanotransduction pathways and membrane trafficking in disease contexts like fibrosis and cancer. His work has pioneered using YAP as a model mechanotransducer to identify novel proteins involved in stiffness sensing. Key studies include the role of Fas/CD95 endocytosis in apoptosis regulation and mechanical control of alternative splicing factors . He has published extensively in journals like Nature Communications and EMBO Journal while coordinating the Marie Curie ITN TRANSPOL and collaborating with institutions like Yale University and TU Dresden. Scientific awards include the Feodor Lynen Fellowship (Alexander von Humboldt Foundation, 2003-2005) Eurotrans-Bio Award (2011, consortium) His research is funded by DFG and the Fritz Thyssen Foundation, with recent work exploring organ-on-a-chip models for Lowe syndrome and gut inflammation.

Janice A. Schrieferمشاهده پروفایل

دانشیار

• Healthcare Quality Improvement
• Patient Safety
• Pediatrics
• +۵ مورد دیگر

Janice A. Schriefer is an Associate Professor in the Department of Pediatrics and Public Health Sciences at the University of Rochester School of Medicine and Dentistry. She serves as Director of Collaborative Partnerships for Quality and Safety at UR Medicine Golisano Children's Hospital and Tutor in the Mastering Medical Information course for 1st-year medical students. Dr.P.H., University of Michigan, Public Health MSN, University of Vermont, Nursing MBA, University of Vermont, Business or Commerce BSN, Hartwick College, Nursing Dr. Schriefer's research focuses on healthcare quality improvement (QI) in pediatric settings, including reducing surgical complications via collaborative partnerships, simulation-based team training for perinatal care, and addressing racial/ethnic disparities in inpatient safety outcomes. She has led initiatives on asthma care, central line infection prevention, and gastrostomy tube safety protocols. Her recent publications (2024-2021) examine QI strategies for respiratory illness management in NICUs, peer support systems for families of medically complex children, and severity scoring tools for hospitalized asthma patients. These works span topics like behavioral health interventions, venous access scoring, and vaccination rate optimization. Over 30+ scientific awards (2009-2024) URMC Quality Institute Associate Scholar HRSA grant collaborations on epilepsy care and delivery room simulation Dr. Schriefer mentors students in the Strong Children's Research Center and RES 995 QI Research Electives. She has worked with researchers from Vermont Oxford Network, Stanford University, and the EquiCenter in Mendon, NY.